Concepedia

Cynthia Barcelon-Yang

CB

Statistics

Publications

6

Citations

129

H-Index

6

Active since

1983

Affiliations

Bristol-Myers Squibb (United States)(Current)

Cynthia Barcelon-Yang is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, antiarrhythmic therapy, and enzyme inhibition.

ORCID

Publications per year

1983–2014

6

Publications

6

[(Arylcarbonyl)oxy]propanolamines. 1. Novel .beta.-blockers with ultrashort duration of action

Sheung-Tsam Kam, W. L. Matier, Cynthia Barcelon-Yang et al. · Journal of Medicinal Chemistry · 1984 · 31 citations

, , +11

Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 3. Modifications to the linkage region (region 3)

David M. Stout, W. L. Matier, Cynthia Barcelon-Yang et al. · Journal of Medicinal Chemistry · 1985 · 26 citations

, , +14

Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 1. Heteroarylamine derivatives

David M. Stout, W. L. Matier, Cynthia Barcelon-Yang et al. · Journal of Medicinal Chemistry · 1983 · 25 citations

, , +12

Intellectual property management of biosequence information from a patent searching perspective

Heahyun Yoo, Chandra S. Ramanathan, Cynthia Barcelon-Yang · World Patent Information · 2005 · 22 citations

, , +14

Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 2. Amides

David M. Stout, W. L. Matier, Cynthia Barcelon-Yang et al. · Journal of Medicinal Chemistry · 1984 · 14 citations

, , +9

1–5 of 6